The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Analysis of clinical markers also showed strongest association between markers of poor liver and metabolic health (including elevated bilirubin, ALT and blood sugar) and highest levels of BA reduction with the TPE+IVIG protocol, predicting that the TPE protocol was most effective in people with poorer health.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.